Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can stem cells mend a broken heart?

Siamak Davani1, Frédéric Deschaseaux, David Chalmers

  • 1Laboratoire de Pharmacologie, EA 479, IFR 133, Faculté de Médecine, CHU Jean Minjoz, 25000 Besançon, France. siamak.davani@ufc.chu.univ-fcomte.fr

Cardiovascular Research
|January 11, 2005
PubMed
Summary

Stem cell therapy offers new hope for regenerating hearts damaged by myocardial infarction (MI). This review explores various stem cell types for cardiac cell therapy (CCT) to improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamics of platelet activation in cold-stored low-titer group O whole blood over 8 days: insights relative to standard platelet concentrates.

Intensive care medicine experimental·2026
Same author

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same author

Machine Learning in HIV Care and Antiretroviral Therapy: Systematic Review.

Journal of medical Internet research·2026
Same author

Vaccination and transfusion safety at the time of expanding use of live attenuated vaccines.

Vox sanguinis·2026
Same author

Severe allergic transfusion reactions to group B/AB plasma or platelets in group O recipients are linked to α-Gal sensitization.

Blood·2026
Same author

Detection of persistent viremia by a live attenuated vaccine strain of the chikungunya virus in a blood donor.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Myocardial infarction (MI) is a primary cause of heart failure globally.
  • Current treatments for MI are insufficient to replace necrotic cardiac myocytes and prevent left ventricular remodeling.
  • Stem cell plasticity presents novel therapeutic avenues for cardiac regeneration.

Purpose of the Study:

  • To review recent experimental data on stem cell sources for cardiac cell therapy (CCT).
  • To discuss the clinical potential of diverse stem cell types in regenerating the infarcted heart.
  • To highlight the need for optimizing stem cell selection for CCT.

Main Methods:

  • Literature review of experimental studies on stem cell therapy for cardiac regeneration.

Related Experiment Videos

  • Analysis of data concerning various stem cell types, including embryonic/foetal stem cells, myoblasts, and bone marrow stem cells.
  • Evaluation of the clinical applicability and potential of different stem cell sources for CCT.

    • Main Results:

    • A wide array of stem/progenitor cells have been investigated for CCT.
    • Experimental data show promise in using stem cells for cardiac repair.
    • The optimal choice of stem cells for effective CCT remains undetermined.

    Conclusions:

    • Stem cell therapy holds significant potential for treating myocardial infarction and heart failure.
    • Further research is needed to optimize stem cell selection and application for CCT.
    • Advancements in stem cell plasticity offer new perspectives for cardiac regeneration strategies.